Publications by authors named "A Knutsen"

Introduction: Computational head injury models are promising tools for understanding and predicting traumatic brain injuries. However, most available head injury models are "average" models that employ a single set of head geometry (e.g.

View Article and Find Full Text PDF

Severe combined immunodeficiency (SCID) is characterized by a severe deficiency in T cell numbers. We analyzed data collected (n = 307) for PHA-based T cell proliferation from the PIDTC SCID protocol 6901, using either a radioactive or flow cytometry method. In comparing the two groups, a smaller number of the patients tested by flow cytometry had <10% of the lower limit of normal proliferation as compared to the radioactive method (p = 0.

View Article and Find Full Text PDF

Background: The Primary Immune Deficiency Treatment Consortium (PIDTC) enrolled children in the United States and Canada onto a retrospective multicenter natural history study of hematopoietic cell transplantation (HCT).

Objective: We investigated outcomes of HCT for severe combined immunodeficiency (SCID).

Methods: We evaluated the chronic and late effects (CLE) after HCT for SCID in 399 patients transplanted from 1982 to 2012 at 32 PIDTC centers.

View Article and Find Full Text PDF

We describe the case of a 10-month-old boy with vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities (VACTERL) association and athymia who developed Omenn syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic granulomatous disease (CGD) is a serious immunodeficiency often treated with hematopoietic cell transplantation (HCT), which has shown a 3-year overall survival rate of 82% in patients studied.
  • Pre-existing inflammatory conditions and infections before HCT did not significantly impact survival, but a lower performance score and HLA mismatches were detrimental to outcomes.
  • Post-transplant, patients experienced significant health improvements, with reduced disease burden and lower medication use compared to non-transplant patients, indicating HCT is a robust treatment option for CGD.
View Article and Find Full Text PDF